
Unilife appoints comms VP from Intel
pharmafile | December 12, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Â Â kevin sellers, unilifeÂ
US developer of injectable drugs Unilife has looked to Intel to appoint a marketing and communications veteran in Kevin Sellers.
As senior vice president of its marketing and communications unit, Sellers will report to Unilife chairman and chief executive Alan Shortall and hold responsibility for investor relations, marketing and public relations.
Prior to joining Unilife, Sellers spent 23 years at Intel Corporation in a variety of marketing, communications and finance functions.
For several years he served as VP of investor relations there but was most recently the VP of creative services and digital marketing where he had responsibility for Intel’s advertising and digital marketing strategy.
Sellers also served in several other strategic roles at Intel including director of corporate brand strategy and director of marketing at Intel Japan, based in Tokyo.
“Unilife is a special company and I am excited to be joining them at this point in my career,” says Sellers. “I am incredibly impressed with the talented technical and management team at Unilife and share their passion to dramatically improve healthcare by enhancing the delivery of injectable therapies. I look forward to helping Alan and the team in establishing the strong brand and corporate reputation the company deserves.”
Unilife also highlights the promotion of Stephen Allan, who has been with the company since 2002, to the position of senior VP of strategic planning.
Related Content

Hikma taps Unilife for pre-filled syringes
Jordanian drugmaker Hikma has signed a strategic-level deal with Unilife for the manufacture of generic …






